Cerebrospinal Fluid Vasopressin, Oxytocin, sopressin, Oxytoc in Alzheimer's Diseasβ-Endorphin

Murray A. Raskind, Ine R. Peskind, Thomas H. Lampe, Steven C. Risse, Gerald J. Taborsky, Daniel Dorsa

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

As a first step toward assessing the status of brain neuropeptide systems that may be involved in Alzheimer's disease (AD), the cerebrospinal fluid (CSF) concentrations of the neuropetides atginine vasopressin, somatostatin, oxytocin, and β-endorphin were measured in patients with AD, normal elderly subjects, and normal young subjects. The plasma arginine vasopressin level was also measured in the three groups. The CSF arginine vasopressin level was significantly lower in patients with AD than in either elderly or young normal subjects, but oxytocin and β-endorphin levels did not differ between groups. The CSF osmolarity also did not differ between groups. The plasma arginine vasopressin level did not significantly differ between groups, but high plasma arginine vasopressin values were absent in the patients with AD. The CSF somatostatin level was significantly lower in patients with AD than in normal elderly persons, but it did not differ in young normal subjects. These results suggest that central vasopressinergic activity may be decreased in AD and central reports of low CSF somatostatin levels in AD.

Original languageEnglish (US)
Pages (from-to)382-388
Number of pages7
JournalArchives of General Psychiatry
Volume43
Issue number4
DOIs
StatePublished - 1986
Externally publishedYes

Fingerprint

Endorphins
Oxytocin
Vasopressins
Cerebrospinal Fluid
Alzheimer Disease
Arginine Vasopressin
Somatostatin
Alzheimer's Disease
Alzheimer
Neuropeptides
Osmolar Concentration
Brain

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Psychiatry and Mental health

Cite this

Cerebrospinal Fluid Vasopressin, Oxytocin, sopressin, Oxytoc in Alzheimer's Diseasβ-Endorphin. / Raskind, Murray A.; Peskind, Ine R.; Lampe, Thomas H.; Risse, Steven C.; Taborsky, Gerald J.; Dorsa, Daniel.

In: Archives of General Psychiatry, Vol. 43, No. 4, 1986, p. 382-388.

Research output: Contribution to journalArticle

Raskind, Murray A. ; Peskind, Ine R. ; Lampe, Thomas H. ; Risse, Steven C. ; Taborsky, Gerald J. ; Dorsa, Daniel. / Cerebrospinal Fluid Vasopressin, Oxytocin, sopressin, Oxytoc in Alzheimer's Diseasβ-Endorphin. In: Archives of General Psychiatry. 1986 ; Vol. 43, No. 4. pp. 382-388.
@article{5d0745a1e4e34169806e0f0c1d97c25c,
title = "Cerebrospinal Fluid Vasopressin, Oxytocin, sopressin, Oxytoc in Alzheimer's Diseasβ-Endorphin",
abstract = "As a first step toward assessing the status of brain neuropeptide systems that may be involved in Alzheimer's disease (AD), the cerebrospinal fluid (CSF) concentrations of the neuropetides atginine vasopressin, somatostatin, oxytocin, and β-endorphin were measured in patients with AD, normal elderly subjects, and normal young subjects. The plasma arginine vasopressin level was also measured in the three groups. The CSF arginine vasopressin level was significantly lower in patients with AD than in either elderly or young normal subjects, but oxytocin and β-endorphin levels did not differ between groups. The CSF osmolarity also did not differ between groups. The plasma arginine vasopressin level did not significantly differ between groups, but high plasma arginine vasopressin values were absent in the patients with AD. The CSF somatostatin level was significantly lower in patients with AD than in normal elderly persons, but it did not differ in young normal subjects. These results suggest that central vasopressinergic activity may be decreased in AD and central reports of low CSF somatostatin levels in AD.",
author = "Raskind, {Murray A.} and Peskind, {Ine R.} and Lampe, {Thomas H.} and Risse, {Steven C.} and Taborsky, {Gerald J.} and Daniel Dorsa",
year = "1986",
doi = "10.1001/archpsyc.1986.01800040092013",
language = "English (US)",
volume = "43",
pages = "382--388",
journal = "JAMA Psychiatry",
issn = "2168-622X",
publisher = "American Medical Association",
number = "4",

}

TY - JOUR

T1 - Cerebrospinal Fluid Vasopressin, Oxytocin, sopressin, Oxytoc in Alzheimer's Diseasβ-Endorphin

AU - Raskind, Murray A.

AU - Peskind, Ine R.

AU - Lampe, Thomas H.

AU - Risse, Steven C.

AU - Taborsky, Gerald J.

AU - Dorsa, Daniel

PY - 1986

Y1 - 1986

N2 - As a first step toward assessing the status of brain neuropeptide systems that may be involved in Alzheimer's disease (AD), the cerebrospinal fluid (CSF) concentrations of the neuropetides atginine vasopressin, somatostatin, oxytocin, and β-endorphin were measured in patients with AD, normal elderly subjects, and normal young subjects. The plasma arginine vasopressin level was also measured in the three groups. The CSF arginine vasopressin level was significantly lower in patients with AD than in either elderly or young normal subjects, but oxytocin and β-endorphin levels did not differ between groups. The CSF osmolarity also did not differ between groups. The plasma arginine vasopressin level did not significantly differ between groups, but high plasma arginine vasopressin values were absent in the patients with AD. The CSF somatostatin level was significantly lower in patients with AD than in normal elderly persons, but it did not differ in young normal subjects. These results suggest that central vasopressinergic activity may be decreased in AD and central reports of low CSF somatostatin levels in AD.

AB - As a first step toward assessing the status of brain neuropeptide systems that may be involved in Alzheimer's disease (AD), the cerebrospinal fluid (CSF) concentrations of the neuropetides atginine vasopressin, somatostatin, oxytocin, and β-endorphin were measured in patients with AD, normal elderly subjects, and normal young subjects. The plasma arginine vasopressin level was also measured in the three groups. The CSF arginine vasopressin level was significantly lower in patients with AD than in either elderly or young normal subjects, but oxytocin and β-endorphin levels did not differ between groups. The CSF osmolarity also did not differ between groups. The plasma arginine vasopressin level did not significantly differ between groups, but high plasma arginine vasopressin values were absent in the patients with AD. The CSF somatostatin level was significantly lower in patients with AD than in normal elderly persons, but it did not differ in young normal subjects. These results suggest that central vasopressinergic activity may be decreased in AD and central reports of low CSF somatostatin levels in AD.

UR - http://www.scopus.com/inward/record.url?scp=0022456108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022456108&partnerID=8YFLogxK

U2 - 10.1001/archpsyc.1986.01800040092013

DO - 10.1001/archpsyc.1986.01800040092013

M3 - Article

VL - 43

SP - 382

EP - 388

JO - JAMA Psychiatry

JF - JAMA Psychiatry

SN - 2168-622X

IS - 4

ER -